The landscape of hematology research in Brazil: an analysis of data from citation databases.
Bibliometrics
Hematology
Research output
Scientific production
Scientometrics
Journal
Hematology, transfusion and cell therapy
ISSN: 2531-1387
Titre abrégé: Hematol Transfus Cell Ther
Pays: Brazil
ID NLM: 101725732
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
03
08
2021
revised:
11
01
2022
accepted:
16
02
2022
medline:
21
3
2022
pubmed:
21
3
2022
entrez:
20
3
2022
Statut:
ppublish
Résumé
Scientometrics is the field concerned with measuring and analyzing academic literature, using specific metrics and data from bibliometric databases. Hematology is a broad area of science and medicine, from which several landmark scientific discoveries have emerged. The aim of this report is to provide a snapshot of the landscape of hematology research in Brazil, based on a comprehensive analysis of published studies in hematology whose authors were affiliated to Brazilian institutions from 1980 to 2020. Articles, reviews and letters to the editor with at least one author affiliated to a Brazilian institution were retrieved from Incytes/Web of Science or Scopus databases. Importantly, only papers classified in the subject area "Hematology" by the embedded algorithms of each database were included. Considering all published papers, Brazil is in the 22nd position, contributing with around 1.1% of papers in this period. A clear and sustained increase in publication output can be observed from the early 1990's to the present moment. Publicly-funded higher education institutions were the main contributors to the development and consolidation of the hematology scientific community, which has grown in diversity, with an increasing number of contributions from private institutions. In regard to funding, public agencies have been and remain by large as the most important funder of research in hematology in Brazil. We suggest that continuous monitoring of the temporal trends of some of the data compiled in our report could potentially contribute to a clearer picture of the development of hematology research in Brazil.
Identifiants
pubmed: 35305939
pii: S2531-1379(22)00034-7
doi: 10.1016/j.htct.2022.02.001
pmc: PMC10433318
pii:
doi:
Types de publication
Journal Article
Langues
eng
Pagination
S57-S67Informations de copyright
Copyright © 2022 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest The authors declare no conflicts of interest.
Références
PLoS One. 2016 Nov 21;11(11):e0166149
pubmed: 27870854
J Hematol Oncol. 2015 Feb 06;8:8
pubmed: 25653049
PLoS Biol. 2016 Sep 06;14(9):e1002542
pubmed: 27599158
Cancer. 2014 Apr 15;120(8):1237-45
pubmed: 24382827
Blood. 2015 Apr 30;125(18):2745-52
pubmed: 25758827
Rev Assoc Med Bras (1992). 2014 Nov-Dec;60(6):542-7
pubmed: 25650854
Nature. 2020 Aug 19;:
pubmed: 32820260
Blood. 2015 Dec 10;126(24):2548-60
pubmed: 26631112
Nature. 2015 Oct 1;526(7571):16-7
pubmed: 26432218
Blood Adv. 2018 Oct 9;2(19):2430-2432
pubmed: 30266817